Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Blas Y, Betancourt"'
Autor:
James D. Katz, Markku Miettinen, Mohammad Hadi Bagheri, Katherine M. Carney, Han Wen, Cornelia Cudrici, Deepak R. Lakshmipathy, Richard M. Siegel, Elisa A. Ferrante, Manfred Boehm, Kam A. Newman, Rebecca D. Huffstutler, Cynthia St. Hilaire, Alessandra Brofferio, Leon J. Nesti, Blas Y. Betancourt
Publikováno v:
Rheumatology (Oxford)
Objectives Arterial calcification due to deficiency of CD73 (ACDC) is a hereditary autosomal recessive ectopic mineralization syndrome caused by loss-of-function mutations in the ecto-5′-nucleotidase gene. Periarticular calcification has been repor
Publikováno v:
Rheumatic Disease Clinics of North America. 44:371-391
Providing safe and effective pharmacotherapy to geriatric patients with rheumatologic disorders is challenging. Multidisciplinary care involving rheumatologists, primary care physicians, and other specialties can optimize benefit and reduce adverse o
Publikováno v:
Arthritis Rheumatol
Publikováno v:
Rheumatic diseases clinics of North America. 44(3)
Providing safe and effective pharmacotherapy to geriatric patients with rheumatological disorders is challenging. Multidisciplinary care involving rheumatologists, primary care physicians and other specialties can optimize benefit and reduce adverse
Autor:
Ernesto L Mola, Sergio Bermúdez-Rojas, Felix Rosales, Blas Y Betancourt, Mayte Ramírez-Navas, Elizeth García-Iglesias, Gisselle Leyva-Gonzalez, José I Fernández-Montequín, Luis H Martinez, Jorge Berlanga-Acosta, Marianela Garcia-Siverio, Katia Galán-Naranjo, Ricardo Silva-Rodriguez
Publikováno v:
Int Wound J
Previous studies have shown that an epidermal growth factor-based formulation (Heberprot-P) can enhance granulation of high-grade diabetic foot ulcers (DFU). The aim of this study was to explore the clinical effects of this administration up to compl
Publikováno v:
BMJ case reports. 2015
Pulmonary aspergillosis presents with a variety of clinical forms including invasive pulmonary aspergillosis, chronic necrotising aspergillosis, aspergilloma, chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Haemo
Autor:
Humberto Facundo-Sánchez, José Santos-Gracia, Pedro Lopez-Saura, Horacio Pérez-López, Blas Y Betancourt, Juan Valiente-Mustelier, Maria Acelia Marrero-Mirayaga, Fidel Manuel Cáceres-Lóriga, Felipe Rodiles-Aldana, Karel Morlans-Hernández
Publikováno v:
Journal of Thrombosis and Thrombolysis. 21:185-190
Background and objectives: Valvular thrombosis is a serious complication in patients with prosthetic heart valves. Traditional treatment is emergency surgery, but thrombolysis provides a non invasive alternative. In this paper we evaluate the efficac
Autor:
Elizeth García-Iglesias, Blas Y Betancourt, Giset Jiménez-López, Leovaldo Alvarez-Falcón, Carmen M Valenzuela-Silva, Francisco Debesa-García, Francisco Hernández-Bernal, María A Marrero-Miragaya, Tania González-López, Pedro Lopez-Saura
Publikováno v:
BMC Clinical Pharmacology
Background Streptokinase (SK) is an effective fibrinolytic agent for the treatment of acute myocardial infarction (AMI). The objective of the present study was to assess the adverse drug reactions (ADRs) associated with intravenous recombinant SK in
Autor:
Lorenzo D, Llerena, Juan J, Quirós, Benito, Sainz, José A, Valdés, Biolkys, Zorio, Luis H, Villanueva, César E, Filgueiras, Francisco, Cabrera, Julio C, Echarte, Jesús M, Pérez del Todo, Israel, Guerrero, Leonardo, López, Ernesto J, García, Betty, Nadal, Blas Y, Betancourt, Gisou, Díaz-Rojo, Ana I, García, Pedro, López-Saura
Publikováno v:
Journal of pharmacypharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 7(3)
Fibrinolytic therapy restores coronary patency and reduces mortality in patients with acute myocardial infarction. Albumin is present in most of the streptokinase formulation as a stabilizer but it is not known whether it plays a role in the product'
Publikováno v:
European Heart Journal. 26:1448-1449
In the study of Hermentin et al. ,1 a significant discrepancy between claimed and measured streptokinase (SK) activity of various tested products was found in addition to other physicochemical differences. However, it is difficult to interpret the re